Literature DB >> 32851461

Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis.

K Gutschmidt1, S Wenninger1, F Montagnese1, B Schoser2.   

Abstract

BACKGROUND: Cognitive impairments in patients with myotonic dystrophy type 1 (DM1) have often been described, however, there are only few studies differentiating between partial performance disorders and mental retardation in common. This study focused on the evaluation of reading performance and the frequency of dyslexia in adult DM1 patients.
METHODS: We performed a prospective cohort study including genetically confirmed adult DM1 patients registered in the DM registry of Germany or the internal database of the Friedrich-Baur-Institute, Munich, Germany. For the assessment of the patients' reading and spelling performance, we used the standardized and validated test 'Salzburger Lese- und Rechtschreibtest' (SLRT II). The 'CFT-20 R Grundintelligenztest Skala 2' in revised ("R") version (CFT 20-R), determining the intelligence level, was appropriate to differentiate between dyslexia and general mental retardation. The diagnosis of dyslexia, the combined reading and spelling disorder, was based on the guidelines for diagnosis and therapy of children and adolescents with dyslexia 2015 (S3-guideline) providing (1) the criterion of the divergence from age level and (2) the criterion of IQ-divergence.
RESULTS: Fifty-seven DM1 patients participated in our study. Evaluating the reading performance, 16 patients fulfilled the divergence criteria of the age level and 2 patients the IQ-divergence criteria. In total, the diagnosis of a reading disorder was given in 18 DM1 patients (31.6 %). In 11 out of these 18 patients with a reading disorder, a relevant impairment of spelling performance was observed with at least three spelling errors. As there are no normative values for adults in spelling performance, we assume a combined reading disorder and dyslexia, in those 11 DM1 patients (19.3 %). Regarding the separate analyses of the test procedures, in the SLRT II the performance was below average in 40.4 % of all patients for 'word reading' and in 61.4 % of all patients for 'pseudoword reading'. There was a significant positive correlation between the CTG expansion size and a reading disorder (p=0.027). The average IQ of 17 examined DM1 patients was in the lower normal range (86.1 ± 19.1). 54.5 % of patients with reading disorder had a normal IQ.
CONCLUSION: The calculated prevalence of dyslexia in the DM1 study cohort was 19.3 % and thus considerably increased compared to the normal German population. As dyslexia is not equivalent to a general cognitive impairment, it is important not to miss dyslexic features in cognitive inconspicuous DM1 patients. Case-by-case one should consider a differential diagnostic approach, as individualized therapies can be offered to support dyslexic patients in their performance.

Entities:  

Keywords:  Cognitive impairment; Dyslexia; IQ; Neurodegenerative; Reading disorder

Mesh:

Year:  2020        PMID: 32851461      PMCID: PMC7880941          DOI: 10.1007/s00415-020-10161-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Authors:  Daniel T Franc; Ryan L Muetzel; Paul R Robinson; Craig P Rodriguez; Joline C Dalton; Cameron E Naughton; Bryon A Mueller; Jeffrey R Wozniak; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2012-01-30       Impact factor: 4.296

2.  Prevalence of myotonic dystrophy type 1 in adults in western Sweden.

Authors:  Christopher Lindberg; Fredrik Bjerkne
Journal:  Neuromuscul Disord       Date:  2016-12-13       Impact factor: 4.296

3.  The Association of Dyslexia and Developmental Speech and Language Disorder Candidate Genes with Reading and Language Abilities in Adults.

Authors:  Catherine Doust; Scott D Gordon; Natalie Garden; Simon E Fisher; Nicholas G Martin; Timothy C Bates; Michelle Luciano
Journal:  Twin Res Hum Genet       Date:  2020-04-06       Impact factor: 1.587

4.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

5.  Sex differences in developmental reading disability: new findings from 4 epidemiological studies.

Authors:  Michael Rutter; Avshalom Caspi; David Fergusson; L John Horwood; Robert Goodman; Barbara Maughan; Terrie E Moffitt; Howard Meltzer; Julia Carroll
Journal:  JAMA       Date:  2004-04-28       Impact factor: 56.272

6.  Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1.

Authors:  A Sistiaga; I Urreta; M Jodar; A M Cobo; J Emparanza; D Otaegui; J J Poza; J J Merino; H Imaz; J F Martí-Massó; A López de Munain
Journal:  Psychol Med       Date:  2009-07-23       Impact factor: 7.723

7.  Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring.

Authors:  J B Redman; R G Fenwick; Y H Fu; A Pizzuti; C T Caskey
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

Review 8.  Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1.

Authors:  Marie Douniol; Aurélia Jacquette; David Cohen; Nicolas Bodeau; Linda Rachidi; Nathalie Angeard; Jean-Marie Cuisset; Louis Vallée; Bruno Eymard; Monique Plaza; Delphine Héron; Jean-Marc Guilé
Journal:  Dev Med Child Neurol       Date:  2012-08-03       Impact factor: 5.449

9.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

10.  Fatigue in myotonic dystrophy type 1: a seven-year prospective study.

Authors:  Stojan Peric; Bogdan Bjelica; Ivo Bozovic; Jovan Pesovic; Teodora Paunic; Marija Banovic; Milos Brkusanin; Ksenija Aleksic; Ivana Basta; Dusanka Savic Pavicevic; Vidosava Rakocevic Stojanovic
Journal:  Acta Myol       Date:  2019-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.